Lucida Medical brings together some of the foremost experts in AI technology and radiology, from leading clinical institutes across Europe.
Our core team is deeply grounded in AI software development and revolutionary applications of medical imaging, both in clinical practice and market development.
Dr Antony Rix
CEO & Co-Founder
Antony has spent the last 30 years researching, working and building companies in artificial intelligence, signal processing and software.
His first startup, Psytechnics (acquired 2011 by Netscout) was built on his PhD research, patents and an international standard that he helped secure. He then gained experience on medical devices and large development programmes as Senior Consultant at TTP, before returning to startups to found industrial sensing specialist 8power. Antony has focused on AI for cancer imaging since 2018.
Professor Evis Sala
Chief Medical Officer & Co-founder
Evis is a Board Certified radiologist and an expert in cancer imaging, radiology and artificial intelligence in healthcare. She serves as Chair of Radiology at Polyclinico Gemelli in Rome, Italy’s leading cancer hospital.
She was previously Chief of Body Imaging, at Memorial Sloan Kettering Cancer Centre and Professor of Radiology, Weill Cornell Medical College, then Professor of Oncological Imaging at the University of Cambridge and Honorary Consultant Radiologist at Addenbrooke’s Hospital.
Dr David Tuch
Chair of the Board
David gained his PhD from MIT and Harvard Medical School working in diffusion-weighted MRI. He served as Global Head of Imaging at Novartis and then as Head of Research Alliances at GE Healthcare, before founding Lightpoint Medical to develop a novel miniaturised gamma ray sensor for surgery for prostate cancer and other conditions. After building the company over 8 years, he now serves as Executive Chair Lightpoint Medical
Chief Technology Officer
Physicist with 30 years of experience in managing complex systems and business processes, including delivery of phase I-III clinical trial programmes for major pharmaceutical companies and innovative biotech and medical device companies.
Former Chief Technology Officer at IAG – Image Analysis Group and Technology Director at Fitch Ratings
Benita has worked with 5 technology start-ups in Cambridge, UK, where she joined all of them at early stage and has been pivotal in the scale-up process. Three of these have been spun out from the University of Cambridge.
She has vast experience in administrative services, including PA/EA support and HR.
Dr Nádia Mackay
Senior Machine Learning Engineer
Nadia is a bioengineer with 8 years of experience in medical imaging analysis, with a focus on using machine learning techniques and graph theory to aid in the prognosis of neurological disorders. Previously she worked as a researcher at INESC-Tec developing imaging solutions for clinical partners.
CLINICAL RESEARCH MANAGER
Steffi brings over 12 years’ experience managing complex clinical trials and research projects, first at Oxford University and then at Ultromics. She led the Ultromics Phase 4 NHSX AI Award where she ensured the rapid deployment of AI in NHS centres. Steffi now leads the Research portfolio at Lucida Medical.
Medical Imaging Entrepreneur
Partner, London Uroradiology
Co-founder of multiple medical imaging and biopsy businesses.
Co-founder, Nuada Medical Group, the pioneer of prostate MRI in private practice 2009 – 2015.
Ran Philips Medical Global Service business 1998 – 2001
Market & business development Advisor
Co-founder, Prostate Matters
Co-founder, Nuada Medical Group 2009 – 2018
Co-founder, Market Equity Ltd a collaboration with Cranfield School of Management 1994 – 2018
Extensive global go-to-market experience with diagnostic imaging companies
Outstanding network of relationships across the prostate diagnosis and treatment market in the UK and Europe
Social Media & Marketing Consultant
Louise is highly experienced at Social Media strategy and execution as well as events promotion and management.
She is also Social Media & Campaign Manager at Prostate Matters and Marketing Events Manager at the International Cancer Imaging Society (ICIS). This gives her a global relationship with many key players in prostate cancer diagnostics.
Louise was previously Training and Conference Manager at Bowel Cancer UK.
Professor Anwar Padhani
Internationally recognised Oncological MRI radiologist and authority on prostate & whole body imaging
Professor of Cancer Imaging, Institute of Cancer Research
Consultant Radiologist & Head of Imaging Research, Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, London
Co-chair, International PI-RADS (prostate imaging) standards group
Professor Guiseppe Petralia
Director, Precision Imaging & Research Unit, European Oncology Institute (IEO)
Associate Professor, Department of Oncology and Hematology-Oncology, University of Milan
Expert on prostate & whole body MRI for oncology screening, diagnosis, biopsy and treatment management
We collaborate with Cambridge University, we are a partner in the ReIMAGINE prostate imaging trial, are in the process of establishing collaborative partnerships with several UK NHS Trust hospitals to help further develop and validate and test Pi, our AI system for detecting prostate cancer from MRI.